Medicskin Holdings Limited (HKG:8307)
Hong Kong
· Delayed Price · Currency is HKD 0.160
0.00 (0.00%)
At close: Mar 10, 2026
Medicskin Holdings Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 45.55 | 45.11 | 49.14 | 45.54 | 49.15 | 41.71 | Upgrade
|
| Other Revenue | 0.79 | 0.84 | 0.75 | 0.48 | 0.04 | - | Upgrade
|
| Revenue | 46.34 | 45.95 | 49.89 | 46.02 | 49.19 | 41.71 | Upgrade
|
| Revenue Growth (YoY) | -2.56% | -7.89% | 8.41% | -6.44% | 17.91% | -13.18% | Upgrade
|
| Cost of Revenue | 31.67 | 32.41 | 34.37 | 32.03 | 27.55 | 26.55 | Upgrade
|
| Gross Profit | 14.67 | 13.54 | 15.52 | 13.99 | 21.63 | 15.17 | Upgrade
|
| Selling, General & Admin | 0.03 | 0.03 | 0.05 | 0.21 | 0.06 | 0.15 | Upgrade
|
| Other Operating Expenses | 8.22 | 8.16 | 8.95 | 7.38 | 8.17 | 7.52 | Upgrade
|
| Operating Expenses | 16.32 | 17.25 | 18.39 | 16.92 | 17.96 | 17.48 | Upgrade
|
| Operating Income | -1.65 | -3.71 | -2.87 | -2.93 | 3.68 | -2.31 | Upgrade
|
| Interest Expense | -0.89 | -0.69 | -0.51 | -0.78 | -0.4 | -0.49 | Upgrade
|
| Interest & Investment Income | 0.97 | 1.01 | 0.66 | 0.52 | 0.45 | 0.61 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.28 | -0.1 | -0.41 | -1.38 | 0.54 | 0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.05 | 0.05 | - | - | 0.03 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -1.8 | -3.44 | -3.13 | -4.57 | 4.3 | -1.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.2 | - | 0.02 | 0.06 | 0.13 | -0.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.61 | - | - | - | - | 0.88 | Upgrade
|
| Asset Writedown | -0 | -0.02 | -0.01 | -0.02 | -0 | -0.02 | Upgrade
|
| Other Unusual Items | - | - | - | 0.83 | - | 2.29 | Upgrade
|
| Pretax Income | -1.39 | -3.46 | -3.12 | -3.7 | 4.42 | 1.31 | Upgrade
|
| Income Tax Expense | -0.08 | -0.08 | -0.02 | -0.11 | 0.28 | -0.05 | Upgrade
|
| Earnings From Continuing Operations | -1.31 | -3.38 | -3.1 | -3.59 | 4.14 | 1.36 | Upgrade
|
| Minority Interest in Earnings | - | 0.01 | 0.05 | 0.05 | -0.22 | -0.41 | Upgrade
|
| Net Income | -1.31 | -3.38 | -3.05 | -3.54 | 3.92 | 0.95 | Upgrade
|
| Net Income to Common | -1.31 | -3.38 | -3.05 | -3.54 | 3.92 | 0.95 | Upgrade
|
| Net Income Growth | - | - | - | - | 311.54% | - | Upgrade
|
| Shares Outstanding (Basic) | 397 | 397 | 397 | 397 | 397 | 421 | Upgrade
|
| Shares Outstanding (Diluted) | 397 | 397 | 397 | 397 | 397 | 421 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | -5.81% | -13.28% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.01 | 0.01 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.01 | 0.01 | 0.00 | Upgrade
|
| EPS Growth | - | - | - | - | 337.00% | - | Upgrade
|
| Free Cash Flow | 5.15 | 8.29 | 9.12 | 0.95 | 1.93 | 6.84 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Gross Margin | 31.66% | 29.47% | 31.10% | 30.39% | 43.98% | 36.36% | Upgrade
|
| Operating Margin | -3.56% | -8.07% | -5.75% | -6.37% | 7.47% | -5.54% | Upgrade
|
| Profit Margin | -2.83% | -7.35% | -6.11% | -7.69% | 7.97% | 2.28% | Upgrade
|
| Free Cash Flow Margin | 11.11% | 18.04% | 18.28% | 2.06% | 3.92% | 16.40% | Upgrade
|
| EBITDA | 0.2 | -1.85 | -0.76 | -0.71 | 5.84 | -0.12 | Upgrade
|
| EBITDA Margin | 0.43% | -4.01% | -1.53% | -1.55% | 11.88% | -0.29% | Upgrade
|
| D&A For EBITDA | 1.85 | 1.87 | 2.11 | 2.22 | 2.17 | 2.19 | Upgrade
|
| EBIT | -1.65 | -3.71 | -2.87 | -2.93 | 3.68 | -2.31 | Upgrade
|
| EBIT Margin | -3.56% | -8.07% | -5.75% | -6.37% | 7.47% | -5.54% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 6.24% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.